Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction
Cell Research, ISSN: 1748-7838, Vol: 29, Issue: 10, Page: 804-819
2019
- 48Citations
- 179Captures
- 14Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations48
- Citation Indexes47
- 47
- CrossRef41
- Patent Family Citations1
- 1
- Captures179
- Readers179
- 179
- Mentions14
- News Mentions12
- 12
- Blog Mentions2
- 2
Most Recent Blog
The Island of Dr Izpisua Belmonte
Human-monkey chimeras arrive to solve the problem of organ shortage. Thank Juan Carlos Izpisua Belmonte, who is ready to cure all possible diseases and even the old age. With chutzpah and Cell on his side.
Most Recent News
SATI gene editing could replace CRISPR
Scientists have developed a new gene editing tool called SATI that is safer than CRISPR.
Article Description
In vivo genome editing represents a powerful strategy for both understanding basic biology and treating inherited diseases. However, it remains a challenge to develop universal and efficient in vivo genome-editing tools for tissues that comprise diverse cell types in either a dividing or non-dividing state. Here, we describe a versatile in vivo gene knock-in methodology that enables the targeting of a broad range of mutations and cell types through the insertion of a minigene at an intron of the target gene locus using an intracellularly linearized single homology arm donor. As a proof-of-concept, we focused on a mouse model of premature-aging caused by a dominant point mutation, which is difficult to repair using existing in vivo genome-editing tools. Systemic treatment using our new method ameliorated aging-associated phenotypes and extended animal lifespan, thus highlighting the potential of this methodology for a broad range of in vivo genome-editing applications.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85071504608&origin=inward; http://dx.doi.org/10.1038/s41422-019-0213-0; http://www.ncbi.nlm.nih.gov/pubmed/31444470; https://www.nature.com/articles/s41422-019-0213-0; https://dx.doi.org/10.1038/s41422-019-0213-0; http://sciencechina.cn/gw.jsp?action=cited_outline.jsp&type=1&id=6581800&internal_id=6581800&from=elsevier
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know